Y Azuma1, A Taniguchi, K Matsumoto
1Department of Clinical Chemistry, School of Pharmaceutical Sciences, Toho University, Funabashi, Chiba, Japan. yutaro@phar.toho-u.ac.jp
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Etoposide treatment rapidly alters Jurkat cell surface glycans, decreasing sialic acids and increasing galactose. This desialylation is primarily caused by increased cell surface sialidase activity during etoposide-induced apoptosis.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: